$31.63−0.08 (−0.25%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD
Option Care Health (OPCH) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
Sources Company filings FilingsHow we compute thisNot investment advice
Business engineChoppy: revenue compounds ~13.2%/yr (FY21→FY25), net margin 3.7%, and free cash flow (~$217.1M) tracks net income. Earnings are cash, not paper. Worth your attention in FY25: Returns vs FCF (143%). Visible in the receipts below.
The four lines that matter · FY21–FY25
Revenue ($M)▲13.0%
5,649.5
FY21→FY25CAGR +13.2%/yr
Net income ($M)▼2.0%
207.6
one-off year: see footnoteCAGR +10.4%/yr
Free cash flow ($M)▼24.5%
217.1
FY21→FY25CAGR +4.4%/yr
Diluted EPS▲3.3%
1.27
buyback-liftedCAGR +13.3%/yr
What the receipts whisper · what a headline number hides
Share count
−9.8%
181.2mn → 163.4mn diluted shares since FY21. Part of EPS growth is the shrinking denominator. Watch net income too.
Capex
$41.3M
+16.0% YoY in FY25 · 0.7% of revenue.
Returns vs FCF
143%
$310.0M returned vs $217.1M of FCF in FY25. The gap comes off the balance sheet (see net cash).
What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)
4¢ of every revenue dollar becomes profit. The biggest cost lever is COGS.
Margin trend · direction beats level Gross Operating Net
Over this window: gross 22.7% → 19.3%. Net margin 3.7% is above the sector median.
The receipt · income statement · FY21–FY25 USD millions except per-share & ratios · hover a line for its definition
USD millions except per-share & ratios
| Line item | TTM † | FY25 | FY24 | FY23 | FY22 | FY21 | YoY | CAGR 21→25 |
|---|---|---|---|---|---|---|---|---|
| Revenue & profitability | ||||||||
Revenue | 5,752.0 | 5,649.5 | 4,998.2 | 4,302.3 | 3,944.7 | 3,438.6 | ▲13.0% | +13.2% |
Cost of revenue | 4,654.9 | 4,561.6 | 3,985.2 | 3,321.1 | 3,077.8 | 2,659.0 | ▲14.5% | +14.4% |
Gross profit | 1,097.1 | 1,087.9 | 1,013.0 | 981.2 | 866.9 | 779.6 | ▲7.4% | +8.7% |
Selling, general & admin | 689.0 | 682.5 | 630.3 | 607.4 | 566.1 | 525.7 | ▲8.3% | +6.7% |
Total operating expenses | 758.7 | 750.0 | 691.2 | 666.6 | 626.7 | 588.8 | ▲8.5% | +6.2% |
Operating incomefeeds ROC rank | 338.4 | 337.9 | 321.8 | 314.6 | 240.2 | 190.8 | ▲5.0% | +15.4% |
Other income, net | −43.0 | −55.0 | −38.2 | 44.1 | −34.5 | −74.3 | — | — |
Pretax income | 295.4 | 282.9 | 283.6 | 358.7 | 205.8 | 116.5 | ▼0.2% | +24.8% |
Income tax | 80.2 | 75.3 | 71.8 | 91.7 | 55.2 | −23.4 | ▲4.9% | +10.9% (22→25) |
Net incomePiotroski ROA ✓feeds Buffett Quality owner earnings | 215.2 | 207.6 | 211.8 | 267.1 | 150.6 | 139.9 | ▼2.0% | +10.4% |
| Per share | ||||||||
Diluted EPSbuyback-sensitive | 1.38 | 1.27 | 1.23 | 1.48 | 0.83 | 0.77 | ▲3.3% | +13.3% |
Diluted shares (mn) | 150.49 | 163.37 | 172.84 | 180.38 | 182.07 | 181.21 | ▼5.5% | −2.6% |
| Margins | ||||||||
Gross margin6th pct in Healthcare | 19.1% | 19.3% | 20.3% | 22.8% | 22.0% | 22.7% | ▼1.0pp | −3.4pp |
Operating margin | 5.9% | 6.0% | 6.4% | 7.3% | 6.1% | 5.5% | ▼0.5pp | +0.4pp |
Net margin52nd pct in Healthcare | 3.7% | 3.7% | 4.2% | 6.2% | 3.8% | 4.1% | ▼0.6pp | −0.4pp |
† TTM = trailing four quarters through 2026-09-30.FY21 effective tax rate was −20% vs a 26% norm for this window, likely a one-time item; see the filing.
5 more years of statements and CSV export are on Premium, and 13 more on Ultimate.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
These lines feed the tenet checklists: see which gates passTenets →Margins & returns continue as sector-ranked ratiosStatistics →
Annual report filed 2026-02-24 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.
Statements normalized in our fundamentals DB · Not investment advice.
Common questions
What was Option Care Health's revenue last fiscal year?
Option Care Health reported revenue of $5,649.5M in fiscal 2025, up 13.0% from fiscal 2024.
What was Option Care Health's net income?
Option Care Health reported net income of $207.6M in fiscal 2025, a net margin of 3.7%.
Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

